Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR) Meeting Abstract
| Authors: | Schmidinger, M.; Motzer, R. J.; Powles, T.; Escudier, B.; Tannir, N. M.; Mainwaring, P. N.; Rini, B. I.; Hammers, H. J.; Donscov, F.; Roth, B.; Peltola, K.; Lee, J. L.; Heng, D. Y. C.; Aftab, D. T.; Hessel, C.; Scheffold, C.; Schwab, G.; Pal, S.; Hutson, T. E.; Choueiri, T. K. |
| Abstract Title: | Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR) |
| Meeting Title: | ECCO2017: European Cancer Congress |
| Journal Title: | European Journal of Cancer |
| Volume: | 72 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Jan 27-30 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-02-01 |
| Start Page: | S187 |
| End Page: | S188 |
| Language: | English |
| ACCESSION: | WOS:000417650200589 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(17)30678-0 |
| Notes: | Meeting Abstract: 2117 -- ECCO European Cancer Congress -- JAN 27-30, 2017 -- Amsterdam, NETHERLANDS -- Source: Wos |
